Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Inventory (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Inventory data on record, last reported at $7.6 million in Q4 2025.

  • For Q4 2025, Inventory fell 14.95% year-over-year to $7.6 million; the TTM value through Dec 2025 reached $7.6 million, down 14.95%, while the annual FY2025 figure was $7.6 million, 14.95% down from the prior year.
  • Inventory reached $7.6 million in Q4 2025 per CLBT's latest filing, down from $8.9 million in the prior quarter.
  • Across five years, Inventory topped out at $10.2 million in Q4 2022 and bottomed at $6.5 million in Q4 2021.
  • Average Inventory over 5 years is $8.6 million, with a median of $8.9 million recorded in 2024.
  • Peak YoY movement for Inventory: skyrocketed 56.29% in 2022, then decreased 14.95% in 2025.
  • A 5-year view of Inventory shows it stood at $6.5 million in 2021, then surged by 56.29% to $10.2 million in 2022, then dropped by 2.32% to $9.9 million in 2023, then dropped by 10.07% to $8.9 million in 2024, then fell by 14.95% to $7.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $7.6 million in Q4 2025, $8.9 million in Q4 2024, and $9.9 million in Q4 2023.